Stock listing
Hanover:RXK3 SELLAS Life Sciences Group, Inc. Aktie
German listing (Hanover) of SELLAS Life Sciences Group, Inc. · home listing NASDAQ:SLS
Follow SELLAS Life Sciences Group, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:SLS
$9.68 USD -0.47 (-4.7%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:SLS
- Day range
- $9.30 – $9.79 USDOct 30, 2026
- Volume
- 6.11M sharesOct 30, 2026
- Market cap
- $1.95B USDAt the close on Oct 30, 2026 · price × 201.9M shares outstanding
- 52-week range
- $1.39 – $15.88 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $80.36M USDMedian day 5.56M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:SLS · Home | $9.68 USD | -0.475 (-4.7%) | 6,106,123 | $9.63 | $9.79 | $9.30 | $10.16 | Close on Oct 30, 2026 |
| Frankfurt:RXK3 | €8.40 EUR | -1.85 (-18.0%) | — | €8.86 | €8.86 | €8.40 | €10.25 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:SLS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $9.68 | -0.475 | -4.7% | $9.63 | $9.79 | $9.30 | 6,106,123 | |
| $10.16 | -0.225 | -2.2% | $10.42 | $11.09 | $9.85 | 8,222,877 | |
| $10.38 | -1.79 | -14.7% | $12.25 | $12.44 | $9.705 | 23,696,258 | |
| $12.17 | +0.83 | +7.3% | $11.33 | $12.29 | $11.25 | 6,184,005 | |
| $11.34 | -0.20 | -1.7% | $11.50 | $11.70 | $11.18 | 3,201,941 | |
| $11.54 | +0.19 | +1.7% | $11.29 | $11.59 | $11.08 | 3,264,700 | |
| $11.35 | -0.79 | -6.5% | $11.91 | $12.37 | $11.12 | 6,508,000 | |
| $12.14 | +0.16 | +1.3% | $12.07 | $12.34 | $11.81 | 5,657,100 | |
| $11.98 | +1.49 | +14.2% | $10.05 | $12.01 | $9.95 | 10,256,900 | |
| $10.49 | +0.51 | +5.1% | $10.10 | $10.85 | $10.04 | 5,614,100 | |
| $9.98 | -1.36 | -12.0% | $11.20 | $11.24 | $9.75 | 15,824,400 | |
| $11.34 | -0.54 | -4.5% | $11.50 | $11.92 | $11.15 | 4,652,000 | |
| $11.88 | -0.53 | -4.3% | $12.21 | $12.44 | $11.71 | 4,743,600 | |
| $12.41 | +0.48 | +4.0% | $11.74 | $12.70 | $11.69 | 6,402,100 | |
| $11.93 | +0.28 | +2.4% | $11.58 | $12.14 | $11.48 | 4,028,700 | |
| $11.65 | +0.39 | +3.5% | $11.38 | $11.81 | $11.26 | 4,178,200 | |
| $11.26 | -0.05 | -0.4% | $11.17 | $11.34 | $10.71 | 4,207,600 | |
| $11.31 | -0.03 | -0.3% | $11.28 | $11.54 | $11.15 | 3,132,300 | |
| $11.34 | -0.29 | -2.5% | $11.63 | $11.67 | $11.11 | 3,982,600 | |
| $11.63 | -0.11 | -0.9% | $11.77 | $11.77 | $11.35 | 4,512,400 | |
| $11.74 | +0.41 | +3.6% | $11.50 | $12.00 | $11.38 | 3,838,800 | |
| $11.33 | -0.98 | -8.0% | $12.15 | $12.25 | $11.20 | 6,220,100 | |
| $12.31 | +0.80 | +7.0% | $11.51 | $12.53 | $11.20 | 8,618,700 | |
| $11.51 | -0.08 | -0.7% | $11.50 | $11.64 | $11.37 | 3,267,200 | |
| $11.59 | -0.02 | -0.2% | $11.51 | $11.85 | $11.31 | 3,752,700 | |
| $11.61 | -0.37 | -3.1% | $11.99 | $12.15 | $11.50 | 4,452,900 | |
| $11.98 | +0.46 | +4.0% | $11.43 | $12.04 | $11.10 | 4,652,600 | |
| $11.52 | -0.50 | -4.2% | $11.92 | $12.14 | $11.42 | 3,888,900 | |
| $12.02 | +0.65 | +5.7% | $11.41 | $12.07 | $11.17 | 5,970,400 | |
| $11.37 | -0.12 | -1.0% | $11.59 | $11.94 | $11.13 | 5,636,400 | |
| $11.49 | -0.04 | -0.3% | $11.60 | $11.78 | $11.06 | 14,607,400 | |
| $11.53 | -0.13 | -1.1% | $11.31 | $11.80 | $11.23 | 4,811,900 | |
| $11.66 | +0.37 | +3.3% | $11.24 | $11.74 | $11.24 | 5,126,200 | |
| $11.29 | -0.44 | -3.8% | $11.60 | $11.70 | $11.03 | 5,244,000 | |
| $11.73 | +0.18 | +1.6% | $10.91 | $12.28 | $10.78 | 10,542,400 | |
| $11.55 | -1.94 | -14.4% | $13.55 | $13.74 | $11.38 | 14,709,900 | |
| $13.49 | -0.46 | -3.3% | $13.66 | $13.83 | $13.37 | 4,820,200 | |
| $13.95 | -0.01 | -0.1% | $13.71 | $14.33 | $13.71 | 5,499,900 | |
| $13.96 | +0.10 | +0.7% | $13.77 | $14.37 | $13.32 | 6,055,000 | |
| $13.86 | +0.16 | +1.2% | $13.51 | $14.14 | $13.43 | 4,526,900 | |
| $13.70 | -0.46 | -3.2% | $14.06 | $14.54 | $13.55 | 5,776,000 | |
| $14.16 | +0.94 | +7.1% | $13.27 | $14.33 | $13.23 | 6,236,300 | |
| $13.22 | -0.12 | -0.9% | $13.02 | $13.39 | $12.64 | 5,911,700 | |
| $13.34 | +0.13 | +1.0% | $13.33 | $13.67 | $12.94 | 7,449,600 | |
| $13.21 | -2.00 | -13.1% | $14.77 | $14.79 | $13.15 | 9,825,400 | |
| $15.21 | +1.48 | +10.8% | $14.08 | $15.56 | $13.92 | 12,117,400 | |
| $13.73 | -0.36 | -2.6% | $13.82 | $13.92 | $13.41 | 4,594,600 | |
| $14.09 | -0.24 | -1.7% | $14.56 | $15.39 | $13.91 | 8,206,800 | |
| $14.33 | -1.13 | -7.3% | $15.48 | $15.48 | $13.91 | 8,823,400 | |
| $15.46 | +2.06 | +15.4% | $13.69 | $15.67 | $13.26 | 15,242,100 | |
| $13.40 | -0.45 | -3.2% | $13.84 | $14.44 | $13.01 | 7,818,900 | |
| $13.85 | +0.75 | +5.7% | $13.46 | $14.29 | $13.00 | 9,123,100 | |
| $13.10 | +0.10 | +0.8% | $12.66 | $13.48 | $12.53 | 4,967,800 | |
| $13.00 | +0.22 | +1.7% | $12.78 | $13.25 | $12.39 | 5,433,300 | |
| $12.78 | +0.42 | +3.4% | $12.40 | $13.00 | $12.18 | 4,413,600 | |
| $12.36 | +0.59 | +5.0% | $11.70 | $12.59 | $11.40 | 5,671,900 | |
| $11.77 | +0.72 | +6.5% | $11.92 | $12.45 | $11.50 | 7,796,800 | |
| $11.05 | +0.01 | +0.1% | $11.27 | $11.39 | $10.85 | 4,723,100 | |
| $11.04 | -0.97 | -8.1% | $11.95 | $12.00 | $10.91 | 5,244,400 | |
| $12.01 | +0.31 | +2.6% | $11.95 | $12.21 | $11.61 | 5,124,100 | |
| $11.70 | -0.16 | -1.3% | $11.62 | $12.18 | $11.59 | 3,769,700 | |
| $11.86 | +0.05 | +0.4% | $11.80 | $12.06 | $11.39 | 5,763,700 | |
| $11.81 | +0.59 | +5.3% | $11.40 | $11.94 | $11.06 | 5,089,800 | |
| $11.22 | +1.21 | +12.1% | $10.00 | $11.43 | $9.80 | 6,968,500 | |
| $10.01 | -0.28 | -2.7% | $10.37 | $10.54 | $9.87 | 5,043,900 | |
| $10.29 | +0.19 | +1.9% | $9.93 | $10.35 | $9.76 | 4,316,300 |
- Ticker
- Hanover:RXK3
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Hanover
- Currency
- EUR
What changed lately
Latest news release · Oct 28, 2026
SELLAS Life Sciences Reaches 80th Event in Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia
Calls
Replays
SELLAS Life Sciences Group (NASDAQ:SLS) Q2 2022 Earnings Call
Thu, Sep 15, 2022 · 1:00 PM ET
Watch Transcript
Latest news
SELLAS Life Sciences Reaches 80th Event in Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia
Oct 28, 2026
Closed $10.38 (-14.7%) on Oct 28, 2026
SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer
Sep 25, 2026
Closed $11.61 (-3.1%) on Sep 25, 2026
SELLAS Life Sciences to Present Preclinical Data on SLS009 in Pancreatic Ductal Adenocarcinoma at the 2026 AACR Conference on Pancreatic Cancer
Sep 2, 2026
Closed $14.16 (+7.1%) on Sep 2, 2026
SELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 12, 2026
Closed $6.53 (+25.1%) on May 13, 2026
SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update
Mar 19, 2026
Closed $5.20 (+5.1%) on Mar 19, 2026
SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference
Mar 17, 2026
Closed $5.04 (-6.0%) on Mar 17, 2026
SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009
Mar 12, 2026
Closed $5.03 (-8.2%) on Mar 12, 2026
SELLAS Life Sciences Enters Agreement with IMPACT-AML to Expand SLS009 Clinical Program into Europe
Jan 14, 2026
Closed $4.11 (-1.0%) on Jan 14, 2026
SELLAS Life Sciences Provides Update on Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML)
Dec 29, 2025
Closed $3.35 (+16.7%) on Dec 29, 2025
Decks
Technical Presentation (November 2024)
Technical · 8 slides · November 2024
Investor Day (September 2022)
Investor day · 17 slides · Sep 15, 2022
Investor Symposium on Galinpepimut-S (August 2021)
Conference · 20 slides · Aug 17, 2021
Investor Day (November 2019)
Investor day · 83 slides · Nov 15, 2019
SELLAS Life Sciences Group, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 12 in the last 12 months · 152 in all · newest Oct 28, 2026 · oldest 2019
- Calls
- 1 call with a replay · 1 with a transcript · latest Sep 15, 2022
- Decks
- 19 decks · latest November 2024
Where SELLAS Life Sciences Group, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SLS · Home listing | NASDAQ | United States | USD |
| gettex:RXK3 | gettex | Germany | EUR |
| BOATS:SLS | BOATS | United States | USD |
| Tradegate:RXK3 | Tradegate | Germany | EUR |
| LS Exchange:A2PU3T | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2PU3T | Lang & Schwarz | Germany | EUR |
| Hamburg:RXK3 | Hamburg | Germany | EUR |
| Dusseldorf:RXK3 | Dusseldorf | Germany | EUR |
| Frankfurt:RXK3 | Frankfurt | Germany | EUR |
| Munich:RXK3 | Munich | Germany | EUR |
| Stuttgart:RXK3 | Stuttgart | Germany | EUR |
| Hanover:RXK3 · This page | Hanover | Germany | EUR |
| Xetra:RXK3 | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about SELLAS Life Sciences Group, Inc.